Fludarabine, Cyclophosphamide, Doxorubicin and Rituximab for the Treatment of Post-transplant Lymphoproliferative Disease (PTLD)
Clinical trial NCT01088724 · COMPLETED
Trial details
- NCT number
- NCT01088724
- Sponsor
- A.O. Ospedale Papa Giovanni XXIII
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Primary completion
- 2010-03-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.